Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project

التفاصيل البيبلوغرافية
العنوان: Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
المؤلفون: Laura MacDonald, Dana Bruden, Scott L. Zeger, Guanhao Chan, Jenna N. Sinkevitch, Karl Gústaf Kristinsson, Khalid Zerouali, Adam L. Cohen, Anne von Gottberg, Eva Morfeldt, Eunice W. Kagucia, Mark van der Linden, Markus Hilty, Stefanie Desmet, Sanjay Jayasinghe, Jolita Mereckiene, Maria Garcia Quesada, Krow Ampofo, Shigeru Suga, Rodrigo Puentes, Grant A. Mackenzie, Sara de Miguel, Daniel R. Feikin, Metka Paragi, J. Anthony G. Scott, Jesus Castilla, Jennifer E. Cornick, Heather Cook, Samir K. Saha, Larisa Savrasova, Kyla Hayford, Kostas Danis, Romina Camilli, Charlotte Gilkison, Jana Kozakova, Julia C. Bennett, Ron Dagan, Shamez N Ladhani, Tuya Mungun, Philippe De Wals, Aalisha Sahu Khan, Theano Georgakopoulou, Maria Deloria Knoll, Inci Yildirim, Laura L. Hammitt, Marta Grgic-Vitek, Marissa K. Hetrich, Jennifer R. Verani, Carmen Muñoz-Almagro, Anna Skoczynska, Lucia Mad'arova, Mirjam J Knol, Brita Askeland Winje, Tamara Pilishvili, Pak-Leung Ho, Maria-Cristina C. Brandileone, J. Pekka Nuorti, Tine Dalby, Jackie Kleynhans, Allison McGeer, James D. Kellner
المساهمون: Team, PSERENADE, Tampere University, Health Sciences
المصدر: Microorganisms
Bennett, Julia C.; Hetrich, Marissa K.; Garcia Quesada, Maria; Sinkevitch, Jenna N.; Knoll, Maria Deloria; Feikin, Daniel R.; Zeger, Scott L.; Kagucia, Eunice W.; Cohen, Adam L.; Ampofo, Krow; Brandileone, Maria-Cristina C.; Bruden, Dana; Camilli, Romina; Castilla, Jesús; Chan, Guanhao; Cook, Heather; Cornick, Jennifer E.; Dagan, Ron; Dalby, Tine; Danis, Kostas; ... (2021). Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms, 9(4) MDPI 10.3390/microorganisms9040696 <http://dx.doi.org/10.3390/microorganisms9040696Test>
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
MICROORGANISMS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Microorganisms : open access journal 9(4), 696 (2021). doi:10.3390/microorganisms9040696 special issue: "Special Issue "Bacterial Meningitis: Epidemiology and Vaccination" / Special Issue Editor: Prof. Dr. James Stuart, Guest Editor"
Microorganisms, Vol 9, Iss 696, p 696 (2021)
Volume 9
Issue 4
بيانات النشر: MDPI, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Vacunas, 0301 basic medicine, Serotype, Pediatrics, MENINGITIS, Antígens, Vacunes, 0302 clinical medicine, invasive pneumococcal disease, Credible interval, Immunologia, 030212 general & internal medicine, PROTECTION, lcsh:QH301-705.5, Vaccines, Pneumococs, Incidence (epidemiology), pneumococcal conjugate vaccines, Antígenos, Pneumococcus, Data availability, 3142 Public health care science, environmental and occupational health, Streptococcus pneumoniae, symbols, Life Sciences & Biomedicine, CONJUGATE VACCINE, Microbiology (medical), medicine.medical_specialty, serotypes, Pneumococcal disease, Streptococcus pneumoniae serotype, Immunology, 030106 microbiology, vaccine impact, Inmunología, Microbiology, 03 medical and health sciences, symbols.namesake, Virology, medicine, Poisson regression, Antigens, Disease burden, BURKINA-FASO, Science & Technology, business.industry, 500 Science, bacterial infections and mycoses, EARLY IMPACT, n/a, lcsh:Biology (General), 570 Life sciences, biology, business
الوصف: Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcaldisease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) containingST1 antigen. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE)project gathered ST1 IPD surveillance data from sites globally and aimed to estimatePCV10/13 impact on ST1 IPD incidence. We estimated ST1 IPD incidence rate ratios (IRRs) comparingthe pre‐PCV10/13 period to each post‐PCV10/13 year by site using a Bayesian multi‐level, mixedeffectsPoisson regression and all‐site IRRs using a linear mixed‐effects regression (N = 45 sites).Following PCV10/13 introduction, the incidence rate (IR) of ST1 IPD declined among all ages. Aftersix years of PCV10/13 use, the all‐site IRR was 0.05 (95% credibility interval 0.04–0.06) for all ages,0.05 (0.04–0.05) for <
5 years of age, 0.08 (0.06–0.09) for 5–17 years, 0.06 (0.05–0.08) for 18–49 years,0.06 (0.05–0.07) for 50–64 years, and 0.05 (0.04–0.06) for ≥65 years. PCV10/13 use in infant immunizationprograms was followed by a 95% reduction in ST1 IPD in all ages after approximately 6years. Limited data availability from the highest ST1 disease burden countries using a 3+0 scheduleconstrains generalizability and data from these settings are needed.
وصف الملف: Electronic; application/pdf; fulltext
اللغة: English
تدمد: 2076-2607
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802e2582d5710336fd03a9942bdc8756Test
https://lirias.kuleuven.be/handle/20.500.12942/692596Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....802e2582d5710336fd03a9942bdc8756
قاعدة البيانات: OpenAIRE